Literature

Diener HC et al. Efficacy aud safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. Cephalgia (1999) 19:581-8

Mueller C et al. D, L-lysine acetylsalicylate + glycine Impairs Coronavirus Replication. J Antivir Antiretrovir (2016)  8:4; DOI:10.4172/jaa.1000151

Kircheis R et al. NF-kB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients. Frontiers in Immunology DOI: 10.3389/fimmu.2020.598444

Tantry US et al. Further evidence for the use of aspirin in COVID-19. International Journal of Cardiology (2021) DOI: 10.1016/j.ijcard.2021.11.021